These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 27173998)
1. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models. Su C; Yang X; Lou J Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998 [TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells. Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson's disease mouse. Wang ZH; Zhang JL; Duan YL; Zhang QS; Li GF; Zheng DL Biomed Pharmacother; 2015 Aug; 74():252-6. PubMed ID: 26349993 [TBL] [Abstract][Full Text] [Related]
4. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease. Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins. Kanagaraj N; Beiping H; Dheen ST; Tay SS Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP Wu KC; Liou HH; Lee CY; Lin CJ Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389 [TBL] [Abstract][Full Text] [Related]
7. miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models. Tao X; Zhang W; Chen C; Tao Y; Tao Y; Chen Z; Zhang G Aging (Albany NY); 2024 May; 16(10):8732-8746. PubMed ID: 38775730 [TBL] [Abstract][Full Text] [Related]
8. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression. Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA Opa interacting protein 5-antisense RNA 1 promotes mitochondrial autophagy and protects SH-SY5Y cells from 1-methyl-4-phenylpyridine-induced damage by binding to microRNA-137 and upregulating NIX. Zhao Y; Xie Y; Yao WY; Wang YY; Song N Kaohsiung J Med Sci; 2022 Mar; 38(3):207-217. PubMed ID: 35049152 [TBL] [Abstract][Full Text] [Related]
10. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease. Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678 [TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease. Sun Q; Zhang Y; Wang S; Yang F; Cai H; Xing Y; Zhou L; Chen S; Wang Y Exp Cell Res; 2022 Aug; 417(1):113132. PubMed ID: 35398161 [TBL] [Abstract][Full Text] [Related]
12. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice. Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA NEAT1 mediates the toxic of Parkinson's disease induced by MPTP/MPP+ via regulation of gene expression. Liu Y; Lu Z Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):841-848. PubMed ID: 29575151 [TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra. Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869 [TBL] [Abstract][Full Text] [Related]
15. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease. Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells. Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467 [TBL] [Abstract][Full Text] [Related]
17. The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain. Issa AR; Sun J; Petitgas C; Mesquita A; Dulac A; Robin M; Mollereau B; Jenny A; Chérif-Zahar B; Birman S Autophagy; 2018; 14(11):1898-1910. PubMed ID: 29989488 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of long non-coding RNA AL049437 mitigates MPP+ -induced neuronal injury in SH-SY5Y cells via the microRNA-205-5p/MAPK1 axis. Zhang L; Wang J; Liu Q; Xiao Z; Dai Q Neurotoxicology; 2020 May; 78():29-35. PubMed ID: 32057949 [TBL] [Abstract][Full Text] [Related]
19. Targeted suppression of chaperone-mediated autophagy by miR-320a promotes α-synuclein aggregation. Li G; Yang H; Zhu D; Huang H; Liu G; Lun P Int J Mol Sci; 2014 Sep; 15(9):15845-57. PubMed ID: 25207598 [TBL] [Abstract][Full Text] [Related]
20. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model. Seo MH; Yeo S Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]